Monday, November 6, 2017
- 9:00AM-11:00AM
-
Abstract Number: 1257
A Scoping Review of Contextual Factors of Patient Decision Aids in Osteoarthritis
Patient Outcomes, Preferences, and Attitudes Poster II- 9:00AM-11:00AM
-
Abstract Number: 1186
A Simple, Self-Assembled Hydrogel Depot for Localized Treatment of Post-Traumatic Osteoarthritis
Osteoarthritis – Clinical Aspects Poster I: Clinical Trials and Interventions- 9:00AM-11:00AM
-
Abstract Number: 1372
A Single Immunosignature Test Accurately Discriminates RA from Related Autoimmune and Inflammatory Disorders
Rheumatoid Arthritis – Clinical Aspects Poster II: Pathophysiology, Autoantibodies, and Disease Activity Measures- 9:00AM-11:00AM
-
Abstract Number: 1468
Abatacept Retention Rates, Overall and By Participating Country, and Prognostic Factors of Retention in Patients with RA: 2-Year Results from a Real-World Observational Study
Rheumatoid Arthritis – Small Molecules, Biologics and Gene Therapy Poster II: Prognostic Factors, Imaging and Miscellaneous Reports- 9:00AM-11:00AM
-
Abstract Number: 1073
Aberrant Cell Signaling in Peripheral Blood Mononuclear Cells upon Interferon Alpha Stimulation in Patients with Primary Sjögren’s Syndrome Associates with Type I Interferon Signature
Innate Immunity and Rheumatic Disease Poster II- 9:00AM-11:00AM
-
Abstract Number: 1318
Abnormal Cerviovaginal Cytology in Adolescents with Systemic Lupus Erythematosus: A Retrospective Case Series
ARHP Reproductive Issues in Rheumatic Disorders Poster- 9:00AM-11:00AM
-
Abstract Number: 1731
Abnormal Responses of γδ T Cell Subsets to Stimulation with Cardiolipin and Zoledronate in Systemic Sclerosis
T Cell Biology and Targets in Autoimmune Disease Poster I- 9:00AM-11:00AM
-
Abstract Number: 1719
Accelerated Wound Healing in Megakaryocyte/Platelet-Specific Fli1 Knockout Mice Due to the up-Regulated Expression of Interferon-γ
Systemic Sclerosis, Fibrosing Syndromes and Raynaud's – Pathogenesis, Animal Models and Genetics Poster II- 9:00AM-11:00AM
-
Abstract Number: 996
Accuracy of Canadian Administrative Health Data in Identifying Patients with Psoriasis and Psoriatic Arthritis Using Primary Care Medical Records As the Reference Standard
Epidemiology and Public Health Poster II: Rheumatic Diseases Other than Rheumatoid Arthritis- 9:00AM-11:00AM
-
Abstract Number: 1630
Achievement of Lupus Low Disease Activity State (LLDAS) in the Early Phase of Systemic Lupus Erythematosus Prevent Damage Accrual
Systemic Lupus Erythematosus – Clinical Aspects and Treatment Poster II: Damage and Comorbidities- 9:00AM-11:00AM
-
Abstract Number: 970
ACPA Activate Challenged Synovial Fibroblasts through a PAD Dependent Mechanism: A Potential Explanation of the “Second Hit Model” in RA
Cytokines, Mediators, Cell-Cell Adhesion, Cell Trafficking and Angiogenesis Poster II: Mesenchymal Cells Do React - But How?- 9:00AM-11:00AM
-
Abstract Number: 1063
Activation of Toll-like Receptor 2 in Human Synovium Explants Increase Tissue Turnover and Secretion of Interleukin-6
Innate Immunity and Rheumatic Disease Poster II- 9:00AM-11:00AM
-
Abstract Number: 1240
Active Disease Is Associated with Dependency in Inflammatory Arthritis
Patient Outcomes, Preferences, and Attitudes Poster II- 9:00AM-11:00AM
-
Abstract Number: 1185
Acupotomy Therapy for Joint Pain Relief of Knee Osteoarthritis-Systematic Review and Meta-Analysis